Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma × Ifosfamide × Clear all

Sponsor

Conditions

Sarcoma 22 Lymphoma 13 Hodgkin Disease 11 Osteosarcoma 10 Lymphoma, Large B-Cell, Diffuse 9 Testicular Neoplasms 8 Teratoma 6 Ovarian Neoplasms 6 Neoplasms 6 Lymphoma, Non-Hodgkin 6 Recurrence 5 Neuroectodermal Tumors, Primitive, Peripheral 5 Testicular Germ Cell Tumor 4 Central Nervous System Neoplasms 4 Burkitt Lymphoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Germ Cell Cancer 3 Neurofibrosarcoma 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, B-Cell 3 Histiocytoma, Malignant Fibrous 3 Fibrosarcoma 3 Endodermal Sinus Tumor 3 Carcinoma, Embryonal 3 Vomiting 2 Seminoma 2 Sarcoma, Synovial 2 Sarcoma, Alveolar Soft Part 2 Rhabdomyosarcoma 2

Interventions

Pemetrexed 11 Cisplatin 10 pembrolizumab 7 Carboplatin 6 Ipilimumab 5 Nivolumab 4 durvalumab 3 LMB-100 3 Gemcitabine 3 tremelimumab 2 tazemetostat 2 anetumab ravtansine 2 Vinorelbine 2 Plicamycin 2 Dexamethasone 2 Cyclophosphamide 2 Bevacizumab 2 vandetanib 1 tocilizumab 1 ribociclib 1 rebastinib 1 pevonedistat 1 olaparib 1 niraparib 1 nintedanib 1 fludarabine phosphate 1 fludarabine 1 epacadostat 1 enzalutamide 1 defactinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡